Gapping down
In reaction to earnings/guidance:
- PATH -14.6%, EXFY -9.4%, MASI -9.3%, PHR -6.1%, SHCR -5.5%, TPX -4.4%, FTK -3.8%, WBA -1.5%, BRZE -1.4%
Select Chinese ADRs showing early weakness:
- IQ -10.9% HCM -5% JD -2.6% BIDU -2.2% BABA -1.5% LI -0.7%
Other news:
- YNDX -21.3% (Yango Deli unit exploring strategic shifts in the UK and France according to Bloomberg)
- FRGI -7.4% (to be removed from S&P SmallCap 600)
- AMLX -6.2% (FDA advisory committee votes 6-4 for "no" on effectiveness of AMX0035 for the treatment of ALS)
- MDV -5.5% (files for $200 mln mixed securities shelf offering)
- BOLT -2.5% (files for $250 mln mixed securities shelf offering)
- HESM -2.5% (prices secondary offering of 8.9 mln shares of Class A stock at $29.50 per share)
- FFIE -1.4% (provides update on status of filings and investigation)
Analyst comments:
- HPQ -4% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- DELL -3.3% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- AMD -2.3% (downgraded to Equal Weight from Overweight at Barclays)
- HUBG -0.9% (downgraded to Equal-Weight from Overweight at Stephens)
